Announce Date | 02/05/2025 |
EPS Normalized Actual | $2.44 (Beat by $0.0099999999999998) |
EPS GAAP Actual | $2.44 (Beat by $0.0099999999999998) |
Revenue Actual | $0.995219B |
Revenue Surprise | Beat by $995.219M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 13.39 | 13.69 | 12.9637 | 14.0624 | 1 |
Dec 2027 | 14.05 | 13.05 | 13.71086 | 14.72847 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.39 | 1.39 | 0.995219B | 3.87% | 995.22M |
FQ3 2024 (Sep 2024) | 1.55 | 1.55 | 0.977872B | 1.81% | 977.87M |
FQ2 2024 (Jun 2024) | 1.28 | 1.28 | 1.02849B | 2.56% | 1028.49M |
FQ1 2024 (Mar 2024) | 1.4 | 1.4 | 0.997431B | 5.44% | 997.43M |
FQ4 2023 (Dec 2023) | 1.64 | 1.64 | 0.956726B | 5.77% | 956.73M |
FQ3 2023 (Sep 2023) | 1.59 | 1.59 | 0.960214B | 7.28% | 960.21M |
FQ2 2023 (Jun 2023) | 1.46 | 1.46 | 1.00217B | 3.25% | 1002.17M |
FQ1 2023 (Mar 2023) | 1.14 | 1.14 | 0.943147B | 100% | 943.15M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 2.57899 | -- | 2.53111 | 2.61758 | 3 |
FQ3 2027 (Jul 2027) | 2.54878 | -- | 2.50147 | 2.58692 | 5 |
FQ2 2027 (Jun 2027) | 2.54878 | -- | 2.50354 | 2.63284 | 5 |
FQ1 2027 (Mar 2027) | 2.27351 | -- | 2.23316 | 2.34849 | 3 |
FQ4 2026 (Oct 2026) | 3.29519 | -- | 3.23402 | 3.3445 | 3 |
FQ3 2026 (Jul 2026) | 3.26849 | -- | 3.20781 | 3.3174 | 5 |
FQ2 2026 (Jun 2026) | 3.22421 | -- | 3.16698 | 3.33055 | 5 |
FQ1 2026 (Mar 2026) | 2.66108 | -- | 2.61385 | 2.74884 | 3 |
FQ4 2025 (Oct 2025) | 2.77692 | 49.94 | 2.72537 | 2.81847 | 4 |
FQ3 2025 (Jul 2025) | 2.69287 | 42.44 | 2.64288 | 2.73317 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 1.63B | -- | 1.61B | 1.65B | 3 |
FQ3 2027 (Jul 2027) | 1.58B | -- | 1.55B | 1.59B | 3 |
FQ2 2027 (Jun 2027) | 4.31B | -- | 4.25B | 4.41B | 6 |
FQ1 2027 (Mar 2027) | 4.07B | -- | 4.01B | 4.17B | 4 |
FQ4 2026 (Oct 2026) | 1.27B | -- | 1.25B | 1.29B | 4 |
FQ3 2026 (Jul 2026) | 1.29B | -- | 1.27B | 1.31B | 5 |
FQ2 2026 (Jun 2026) | 1.27B | -- | 1.26B | 1.31B | 6 |
FQ1 2026 (Mar 2026) | 1.19B | -- | 1.18B | 1.23B | 4 |
FQ4 2025 (Oct 2025) | 1.12B | 10.78 | 1.1B | 1.13B | 2 |
FQ3 2025 (Jul 2025) | 1.13B | 13.17 | 1.11B | 1.14B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.39 | 1.39 | 100% | |
FQ3 2024 (Sep 2024) | 1.55 | 1.55 | 100% | |
FQ2 2024 (Jun 2024) | 1.28 | 1.28 | 100% | |
FQ1 2024 (Mar 2024) | 1.4 | 1.4 | 100% | |
FQ4 2023 (Dec 2023) | 1.64 | 1.64 | 100% | |
FQ3 2023 (Sep 2023) | 1.59 | 1.59 | 100% | |
FQ2 2023 (Jun 2023) | 1.46 | 1.46 | 100% | |
FQ1 2023 (Mar 2023) | 1.14 | 1.14 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $1B | $995.22M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.98B | $977.87M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.03B | $1028.49M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1B | $997.43M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.96B | $956.73M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.96B | $960.21M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1B | $1002.17M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.94B | $943.15M | 100% |